{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:31:36Z","timestamp":1790242296704,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T00:00:00Z","timestamp":1415404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00109-014-1214-6","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T16:48:57Z","timestamp":1415983737000},"page":"211-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter"],"prefix":"10.1007","volume":"93","author":[{"given":"Pei-Hsin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"McMasters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Sam","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,8]]},"reference":[{"key":"1214_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nurt.2009.04.011","volume":"6","author":"JN Parker","year":"2009","unstructured":"Parker JN, Bauer DF, Cody JJ, Markert JM (2009) Oncolytic viral therapy of malignant glioma. Neurotherapeutics 6:558\u2013569","journal-title":"Neurotherapeutics"},{"key":"1214_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398342-8.00003-3","volume":"115","author":"WS Wold","year":"2012","unstructured":"Wold WS, Toth K (2012) Chapter three\u2013Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds. Adv Cancer Res 115:69\u201392","journal-title":"Adv Cancer Res"},{"key":"1214_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","volume":"7","author":"W Yu","year":"2007","unstructured":"Yu W, Fang H (2007) Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 7:141\u2013148","journal-title":"Curr Cancer Drug Targets"},{"key":"1214_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301377","volume":"8","author":"D Kirn","year":"2001","unstructured":"Kirn D (2001) Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther 8:89\u201398","journal-title":"Gene Ther"},{"key":"1214_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712590903559822","volume":"10","author":"K Toth","year":"2010","unstructured":"Toth K, Dhar D, Wold WS (2010) Oncolytic (replication-competent) adenoviruses as anticancer agents. Expert Opin Biol Ther 10:353\u2013368","journal-title":"Expert Opin Biol Ther"},{"key":"1214_CR6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1172\/JCI9180","volume":"106","author":"T Kurihara","year":"2000","unstructured":"Kurihara T, Brough DE, Kovesdi I, Kufe DW (2000) Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. J Clin Invest 106:763\u2013771","journal-title":"J Clin Invest"},{"key":"1214_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2012.09.003","volume":"328","author":"X Dong","year":"2013","unstructured":"Dong X, Qu W, Ma S, Zhu Z, Zheng C, He A, Karlsson A, Xu K, Zheng X (2013) Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo. Cancer Lett 328:95\u2013103","journal-title":"Cancer Lett"},{"key":"1214_CR8","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/JVI.01708-07","volume":"82","author":"X Zheng","year":"2008","unstructured":"Zheng X, Rao XM, Gomez-Gutierrez JG, Hao H, McMasters KM, Zhou HS (2008) Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication. J Virol 82:3415\u20133427","journal-title":"J Virol"},{"key":"1214_CR9","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1128\/JVI.72.12.9470-9478.1998","volume":"72","author":"T Rothmann","year":"1998","unstructured":"Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, zur Hausen H (1998) Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol 72:9470\u20139478","journal-title":"J Virol"},{"key":"1214_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ccr.2005.06.009","volume":"8","author":"CC O\u2019Shea","year":"2005","unstructured":"O\u2019Shea CC, Soria C, Bagus B, McCormick F (2005) Heat shock phenocopies E1B-55\u00a0K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy. Cancer Cell 8:61\u201374","journal-title":"Cancer Cell"},{"key":"1214_CR11","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-08-1161","volume":"15","author":"EG Cafferata","year":"2009","unstructured":"Cafferata EG, Maccio DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL (2009) A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Clin Cancer Res 15:3037\u20133049","journal-title":"Clin Cancer Res"},{"key":"1214_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00109-007-0291-1","volume":"86","author":"DM Nettelbeck","year":"2008","unstructured":"Nettelbeck DM (2008) Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer. J Mol Med (Berl) 86:363\u2013377","journal-title":"J Mol Med (Berl)"},{"key":"1214_CR13","doi-asserted-by":"crossref","first-page":"d1369","DOI":"10.2741\/ben","volume":"7","author":"H Ben-Israel","year":"2002","unstructured":"Ben-Israel H, Kleinberger T (2002) Adenovirus and cell cycle control. Front Biosci 7:d1369\u2013d1395","journal-title":"Front Biosci"},{"key":"1214_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mt.2009.262","volume":"18","author":"J Nemunaitis","year":"2010","unstructured":"Nemunaitis J, Tong AW, Nemunaitis M, Senzer N, Phadke AP, Bedell C, Adams N, Zhang YA, Maples PB, Chen S et al (2010) A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol Ther 18:429\u2013434","journal-title":"Mol Ther"},{"key":"1214_CR15","first-page":"7464","volume":"61","author":"TL DeWeese","year":"2001","unstructured":"DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R et al (2001) A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res 61:7464\u20137472","journal-title":"Cancer Res"},{"key":"1214_CR16","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/sj.gt.3302029","volume":"10","author":"X Fu","year":"2003","unstructured":"Fu X, Meng F, Tao L, Jin A, Zhang X (2003) A strict-late viral promoter is a strong tumor-specific promoter in the context of an oncolytic herpes simplex virus. Gene Ther 10:1458\u20131464","journal-title":"Gene Ther"},{"key":"1214_CR17","first-page":"217","volume":"1785","author":"ZS Guo","year":"2008","unstructured":"Guo ZS, Thorne SH, Bartlett DL (2008) Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim Biophys Acta 1785:217\u2013231","journal-title":"Biochim Biophys Acta"},{"key":"1214_CR18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.cgt.7700944","volume":"13","author":"JJ Davis","year":"2006","unstructured":"Davis JJ, Wang L, Dong F, Zhang L, Guo W, Teraishi F, Xu K, Ji L, Fang B (2006) Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter. Cancer Gene Ther 13:720\u2013723","journal-title":"Cancer Gene Ther"},{"key":"1214_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.exer.2009.03.007","volume":"89","author":"X Ji","year":"2009","unstructured":"Ji X, Zhang J, Cheng L, Wei F, Li H, Liu X, Chen X, Li C, Wang Y, Huang Q (2009) Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model. Exp Eye Res 89:193\u2013199","journal-title":"Exp Eye Res"},{"key":"1214_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ccr.2007.05.009","volume":"12","author":"X Xie","year":"2007","unstructured":"Xie X, Xia W, Li Z, Kuo HP, Liu Y, Ding Q, Zhang S, Spohn B, Yang Y, Wei Y et al (2007) Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell 12:52\u201365","journal-title":"Cancer Cell"},{"key":"1214_CR21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.virol.2006.02.009","volume":"350","author":"XM Rao","year":"2006","unstructured":"Rao XM, Zheng X, Waigel S, Zacharias W, McMasters KM, Zhou HS (2006) Gene expression profiles of normal human lung cells affected by adenoviral E1B. Virology 350:418\u2013428","journal-title":"Virology"},{"key":"1214_CR22","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/MCB.15.5.2612","volume":"15","author":"M Ohtsubo","year":"1995","unstructured":"Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612\u20132624","journal-title":"Mol Cell Biol"},{"key":"1214_CR23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ncb813","volume":"4","author":"D Coverley","year":"2002","unstructured":"Coverley D, Laman H, Laskey RA (2002) Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol 4:523\u2013528","journal-title":"Nat Cell Biol"},{"key":"1214_CR24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1083\/jcb.152.6.1267","volume":"152","author":"L Furstenthal","year":"2001","unstructured":"Furstenthal L, Kaiser BK, Swanson C, Jackson PK (2001) Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication. J Cell Biol 152:1267\u20131278","journal-title":"J Cell Biol"},{"key":"1214_CR25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.283.5403.851","volume":"283","author":"EH Hinchcliffe","year":"1999","unstructured":"Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851\u2013854","journal-title":"Science"},{"key":"1214_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0960-9822(99)80191-2","volume":"9","author":"Y Matsumoto","year":"1999","unstructured":"Matsumoto Y, Hayashi K, Nishida E (1999) Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9:429\u2013432","journal-title":"Curr Biol"},{"key":"1214_CR27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1096\/fasebj.13.8.773","volume":"13","author":"R Donnellan","year":"1999","unstructured":"Donnellan R, Chetty R (1999) Cyclin E in human cancers. FASEB J 13:773\u2013780","journal-title":"FASEB J"},{"key":"1214_CR28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres M, Barbacid M (2001) To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1:222\u2013231","journal-title":"Nat Rev Cancer"},{"key":"1214_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/45836","volume":"401","author":"CH Spruck","year":"1999","unstructured":"Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401:297\u2013300","journal-title":"Nature"},{"key":"1214_CR30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0960-9822(02)01225-3","volume":"12","author":"AC Minella","year":"2002","unstructured":"Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE (2002) p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 12:1817\u20131827","journal-title":"Curr Biol"},{"key":"1214_CR31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/MCB.17.1.453","volume":"17","author":"DM Bortner","year":"1997","unstructured":"Bortner DM, Rosenberg MP (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17:453\u2013459","journal-title":"Mol Cell Biol"},{"key":"1214_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2005.06.010","volume":"8","author":"KR Loeb","year":"2005","unstructured":"Loeb KR, Kostner H, Firpo E, Norwood T, Tsuchiya DK, Clurman BE, Roberts JM (2005) A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8:35\u201347","journal-title":"Cancer Cell"},{"key":"1214_CR33","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1158\/1940-6207.CAPR-10-0297","volume":"3","author":"SJ Freemantle","year":"2010","unstructured":"Freemantle SJ, Dmitrovsky E (2010) Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention. Cancer Prev Res (Phila) 3:1513\u20131518","journal-title":"Cancer Prev Res (Phila)"},{"key":"1214_CR34","doi-asserted-by":"crossref","first-page":"e57340","DOI":"10.1371\/journal.pone.0057340","volume":"8","author":"PH Cheng","year":"2013","unstructured":"Cheng PH, Rao XM, McMasters KM, Zhou HS (2013) Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E. PLoS ONE 8:e57340","journal-title":"PLoS ONE"},{"key":"1214_CR35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.virol.2012.09.003","volume":"433","author":"JG Gomez-Gutierrez","year":"2012","unstructured":"Gomez-Gutierrez JG, Rao XM, Zhou HS, McMasters KM (2012) Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus. Virology 433:538\u2013547","journal-title":"Virology"},{"key":"1214_CR36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","volume":"37","author":"L Hayflick","year":"1965","unstructured":"Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614\u2013636","journal-title":"Exp Cell Res"},{"key":"1214_CR37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1101\/gad.7.4.546","volume":"7","author":"M Debbas","year":"1993","unstructured":"Debbas M, White E (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7:546\u2013554","journal-title":"Genes Dev"},{"key":"1214_CR38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(90)90525-V","volume":"177","author":"A Braithwaite","year":"1990","unstructured":"Braithwaite A, Nelson C, Skulimowski A, McGovern J, Pigott D, Jenkins J (1990) Transactivation of the p53 oncogene by E1a gene products. Virology 177:595\u2013605","journal-title":"Virology"},{"key":"1214_CR39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","volume":"92","author":"J Pomerantz","year":"1998","unstructured":"Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW et al (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2\u2019s inhibition of p53. Cell 92:713\u2013723","journal-title":"Cell"},{"key":"1214_CR40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.7.4.535","volume":"7","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7:535\u2013545","journal-title":"Genes Dev"},{"key":"1214_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.cdd.4400618","volume":"7","author":"BM Putzer","year":"2000","unstructured":"Putzer BM, Stiewe T, Parssanedjad K, Rega S, Esche H (2000) E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products. Cell Death Differ 7:177\u2013188","journal-title":"Cell Death Differ"},{"key":"1214_CR42","first-page":"467","volume":"11","author":"JG Teodoro","year":"1995","unstructured":"Teodoro JG, Shore GC, Branton PE (1995) Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11:467\u2013474","journal-title":"Oncogene"},{"key":"1214_CR43","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/emboj\/18.8.2040","volume":"18","author":"A Samali","year":"1999","unstructured":"Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S (1999) Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J 18:2040\u20132048","journal-title":"EMBO J"},{"key":"1214_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","volume":"376","author":"DW Nicholson","year":"1995","unstructured":"Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA et al (1995) Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis. Nature 376:37\u201343","journal-title":"Nature"},{"key":"1214_CR45","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1523\/JNEUROSCI.23-22-07967.2003","volume":"23","author":"P Garnier","year":"2003","unstructured":"Garnier P, Ying W, Swanson RA (2003) Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. J Neurosci 23:7967\u20137973","journal-title":"J Neurosci"},{"key":"1214_CR46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1101\/gad.183509.111","volume":"26","author":"X Luo","year":"2012","unstructured":"Luo X, Kraus WL (2012) On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev 26:417\u2013432","journal-title":"Genes Dev"},{"key":"1214_CR47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.ASN.0000111248.23454.19","volume":"15","author":"P Clark","year":"2004","unstructured":"Clark P, Dziarmaga A, Eccles M, Goodyer P (2004) Rescue of defective branching nephrogenesis in renal-coloboma syndrome by the caspase inhibitor, Z-VAD-fmk. J Am Soc Nephrol 15:299\u2013305","journal-title":"J Am Soc Nephrol"},{"key":"1214_CR48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","volume":"5","author":"Y Kondo","year":"2005","unstructured":"Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726\u2013734","journal-title":"Nat Rev Cancer"},{"key":"1214_CR49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2011.04.017","volume":"416","author":"H Rodriguez-Rocha","year":"2011","unstructured":"Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, Rao XM, Chen L, McMasters KM, Zhou HS (2011) Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 416:9\u201315","journal-title":"Virology"},{"key":"1214_CR50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00281-010-0226-8","volume":"32","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Lee S, Jung JU (2010) When autophagy meets viruses: a double-edged sword with functions in defense and offense. Semin Immunopathol 32:323\u2013341","journal-title":"Semin Immunopathol"},{"key":"1214_CR51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1139\/Y10-010","volume":"88","author":"Y Chen","year":"2010","unstructured":"Chen Y, Azad MB, Gibson SB (2010) Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol 88:285\u2013295","journal-title":"Can J Physiol Pharmacol"},{"key":"1214_CR52","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720\u20135728","journal-title":"EMBO J"},{"key":"1214_CR53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/path.2694","volume":"221","author":"S Barth","year":"2010","unstructured":"Barth S, Glick D, Macleod KF (2010) Autophagy: assays and artifacts. J Pathol 221:117\u2013124","journal-title":"J Pathol"},{"key":"1214_CR54","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.biocel.2004.02.005","volume":"36","author":"N Mizushima","year":"2004","unstructured":"Mizushima N (2004) Methods for monitoring autophagy. Int J Biochem Cell Biol 36:2491\u20132502","journal-title":"Int J Biochem Cell Biol"},{"key":"1214_CR55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(08)03612-4","volume":"452","author":"G Bjorkoy","year":"2009","unstructured":"Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T (2009) Monitoring autophagic degradation of p62\/SQSTM1. Methods Enzymol 452:181\u2013197","journal-title":"Methods Enzymol"},{"key":"1214_CR56","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T (2007) p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131\u201324145","journal-title":"J Biol Chem"},{"key":"1214_CR57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4161\/auto.6.6.12510","volume":"6","author":"KB Larsen","year":"2010","unstructured":"Larsen KB, Lamark T, Overvatn A, Harneshaug I, Johansen T, Bjorkoy G (2010) A reporter cell system to monitor autophagy based on p62\/SQSTM1. Autophagy 6:784\u2013793","journal-title":"Autophagy"},{"key":"1214_CR58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/aps.2012.184","volume":"34","author":"XJ Zhang","year":"2013","unstructured":"Zhang XJ, Chen S, Huang KX, Le WD (2013) Why should autophagic flux be assessed? Acta Pharmacol Sin 34:595\u2013599","journal-title":"Acta Pharmacol Sin"},{"key":"1214_CR59","first-page":"33","volume":"9","author":"S Wadler","year":"2003","unstructured":"Wadler S, Yu B, Tan JY, Kaleya R, Rozenblit A, Makower D, Edelman M, Lane M, Hyjek E, Horwitz M (2003) Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants. Clin Cancer Res 9:33\u201343","journal-title":"Clin Cancer Res"},{"key":"1214_CR60","first-page":"2354","volume-title":"Fields virology","author":"AJ Berk","year":"2006","unstructured":"Berk AJ (2006) Adenoviridae: the viruses and their replication. In: Howley DMKP (ed) Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp 2354\u20132394"},{"key":"1214_CR61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1634\/theoncologist.7-2-106","volume":"7","author":"JT Mullen","year":"2002","unstructured":"Mullen JT, Tanabe KK (2002) Viral oncolysis. Oncologist 7:106\u2013119","journal-title":"Oncologist"},{"key":"1214_CR62","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4161\/cbt.4.5.1820","volume":"4","author":"D Kuruppu","year":"2005","unstructured":"Kuruppu D, Tanabe KK (2005) Viral oncolysis by herpes simplex virus and other viruses. Cancer Biol Ther 4:524\u2013531","journal-title":"Cancer Biol Ther"},{"key":"1214_CR63","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1128\/JVI.71.5.3526-3533.1997","volume":"71","author":"E Querido","year":"1997","unstructured":"Querido E, Teodoro JG, Branton PE (1997) Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J Virol 71:3526\u20133533","journal-title":"J Virol"},{"key":"1214_CR64","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.cgt.7700739","volume":"11","author":"XM Rao","year":"2004","unstructured":"Rao XM, Tseng MT, Zheng X, Dong Y, Jamshidi-Parsian A, Thompson TC, Brenner MK, McMasters KM, Zhou HS (2004) E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells. Cancer Gene Ther 11:585\u2013593","journal-title":"Cancer Gene Ther"},{"key":"1214_CR65","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/sj.onc.1207521","volume":"23","author":"D Gozuacik","year":"2004","unstructured":"Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891\u20132906","journal-title":"Oncogene"},{"key":"1214_CR66","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.it.2012.06.003","volume":"33","author":"F Randow","year":"2012","unstructured":"Randow F, Munz C (2012) Autophagy in the regulation of pathogen replication and adaptive immunity. Trends Immunol 33:475\u2013487","journal-title":"Trends Immunol"},{"key":"1214_CR67","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.0606537104","volume":"104","author":"Y Ma","year":"2007","unstructured":"Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, Robbins DJ, Bentley HA, Tsongalis GJ, Demidenko E et al (2007) Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A 104:4089\u20134094","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1214_CR68","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1078-0432.CCR-08-1355","volume":"15","author":"X Liu","year":"2009","unstructured":"Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H et al (2009) Uncovering growth-suppressive microRNAs in lung cancer. Clin Cancer Res 15:1177\u20131183","journal-title":"Clin Cancer Res"},{"key":"1214_CR69","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","volume":"156","author":"DD Barker","year":"1987","unstructured":"Barker DD, Berk AJ (1987) Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156:107\u2013121","journal-title":"Virology"},{"key":"1214_CR70","first-page":"7840","volume":"63","author":"H Kakinuma","year":"2003","unstructured":"Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC (2003) Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res 63:7840\u20137844","journal-title":"Cancer Res"},{"key":"1214_CR71","first-page":"1173","volume":"12","author":"Y Geng","year":"1996","unstructured":"Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173\u20131180","journal-title":"Oncogene"},{"key":"1214_CR72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1743-422X-10-293","volume":"10","author":"PH Cheng","year":"2013","unstructured":"Cheng PH, Lian S, Zhao R, Rao XM, McMasters KM, Zhou HS (2013) Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells. Virol J 10:293","journal-title":"Virol J"},{"key":"1214_CR73","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1073\/pnas.91.19.8802","volume":"91","author":"AJ Bett","year":"1994","unstructured":"Bett AJ, Haddara W, Prevec L, Graham FL (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 91:8802\u20138806","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1214_CR74","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1248\/bpb.19.1518","volume":"19","author":"M Ishiyama","year":"1996","unstructured":"Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K (1996) A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518\u20131520","journal-title":"Biol Pharm Bull"},{"key":"1214_CR75","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/1078-0432.CCR-10-0664","volume":"16","author":"OJ Kwon","year":"2010","unstructured":"Kwon OJ, Kim PH, Huyn S, Wu L, Kim M, Yun CO (2010) A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas. Clin Cancer Res 16:6071\u20136082","journal-title":"Clin Cancer Res"},{"key":"1214_CR76","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.cgt.7700923","volume":"13","author":"X Zheng","year":"2006","unstructured":"Zheng X, Rao XM, Snodgrass CL, McMasters KM, Zhou HS (2006) Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells. Cancer Gene Ther 13:572\u2013583","journal-title":"Cancer Gene Ther"},{"key":"1214_CR77","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","volume":"97","author":"V Sandig","year":"2000","unstructured":"Sandig V, Youil R, Bett AJ, Franlin LL, Oshima M, Maione D, Wang F, Metzker ML, Savino R, Caskey CT (2000) Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A 97:1002\u20131007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1214_CR78","first-page":"3073","volume":"63","author":"T Zhao","year":"2003","unstructured":"Zhao T, Rao XM, Xie X, Li L, Thompson TC, McMasters KM, Zhou HS (2003) Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo. Cancer Res 63:3073\u20133078","journal-title":"Cancer Res"},{"key":"1214_CR79","first-page":"142","volume":"3","author":"T Huang","year":"2013","unstructured":"Huang T, Civelek AC, Zheng H, Ng CK, Duan X, Li J, Postel GC, Shen B, Li XF (2013) (18)F-Misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings. Am J Nucl Med Mol Imaging 3:142\u2013153","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"1214_CR80","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/jnci\/djm229","volume":"99","author":"K Kurozumi","year":"2007","unstructured":"Kurozumi K, Hardcastle J, Thakur R, Yang M, Christoforidis G, Fulci G, Hochberg FH, Weissleder R, Carson W, Chiocca EA et al (2007) Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. J Natl Cancer Inst 99:1768\u20131781","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1214-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-014-1214-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1214-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T20:41:39Z","timestamp":1598474499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-014-1214-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,8]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["1214"],"URL":"https:\/\/doi.org\/10.1007\/s00109-014-1214-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,8]]}}}